Ratnakar Securities Pvt. Ltd.

VENUS REMEDIES LTD.

NSE : VENUSREMBSE : 526953ISIN CODE : INE411B01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE426.30-13 (-2.96 %)

PREV CLOSE ( ) 439.30

OPEN PRICE ( ) 435.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4816

TODAY'S LOW / HIGH ( )425.00 435.00

52 WK LOW / HIGH ( )272.2 474.8

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1989

Management Info

Pawan Chaudhary - Chairman Pawan Chaudhary - Managing Director

Registered Office

Address S. C. O. 857, C. No. 10,2nd Floor,N A C Manimajra,
Chandigarh,
Union Territory-160101

Phone 0172-2561244/5577

Email info@venusremedies.com

Website www.venusremedies.com / www.vmrcindia.com

Registrars Details

MUFG Intime India Pvt Ltd.

Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi

Listing : BSE, NSE

NEWS

22May Venus Remedies secures Ukrainian GMP r
Venus Remedies has successfully renewed its Good Manufacturing Practices..

22May Venus Remedies rises on securing Ukrai
Venus Remedies is currently trading at Rs. 351.60, up by 2.30 points or..

17Apr USFDA grants QIDP Designation to Venus
United States Food and Drug Administration (USFDA) has granted Qualified..

25Feb Venus Remedies informs about press rel
Venus Remedies has informed that it enclosed a press release titled â€˜V..

25Feb Venus Remedies sings license agreement
Venus Remedies has entered into an exclusive license agreement with lnfe..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	147.9	525.5
Gross Profit	248.3	790.6
Operating Profit	293.2	907.7
Net Sales	1940.4	6394.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Krebs Biochem.&Inds (BSE) 96.02 (20.00%)	M.Cap ( in Cr)207.02
Trident Lifeline (BSE) 287.00 (5.83%)	M.Cap ( in Cr)330.03
Oxygenta Pharma (BSE) 124.41 (14.40%)	M.Cap ( in Cr)460.11
Aayush Wellness (BSE) 148.10 (2.00%)	M.Cap ( in Cr)720.83
Source Natural Foods (BSE) 174.85 (1.54%)	M.Cap ( in Cr)112.55

Shareholding Pattern

	NON-INSTITUTION	56.9%
	PROMOTERS	41.76%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Motilal Oswal BSE H...	0.03

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

VENUS REMEDIES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES